Make your own free website on Tripod.com
Amiodarone (Class IIb) and procainamide (Class IIb) are
recommended ahead of lidocaine and adenosine for the initial
treatment of hemodynamically stable wide-complex tachycardia,
especially in patients with Compromised cardiac function.
Amiodarone and sotalol (a drug that awaits Food and Drug
Administration approval for US use) are new agents recommended as
Class IIa agents for the treatment of stable monomorphic and
polymorphic ventricular tachycardia (VT).
Magnesium has shown effectiveness only in the treatment of known
hypomagnesemic states and torsades de pointes, for which it still has
a Class IIb recommendation.
MOBILE : 9890001567